ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.55% | 15.15% | 8.75% | -0.98% | -11.38% |
| Total Other Revenue | -- | -350.00% | -348.85% | -360.00% | -150.00% |
| Total Revenue | 21.55% | 15.41% | 9.25% | -0.75% | -11.37% |
| Cost of Revenue | 30.89% | 15.82% | 1.46% | -7.75% | -17.19% |
| Gross Profit | 20.19% | 15.36% | 10.42% | 0.32% | -10.46% |
| SG&A Expenses | 0.01% | -2.94% | -5.92% | -1.86% | 0.84% |
| Depreciation & Amortization | 99.87% | 64.37% | 32.30% | 11.51% | -11.08% |
| Other Operating Expenses | -20.57% | 0.80% | 25.23% | -2.99% | -22.68% |
| Total Operating Expenses | 5.62% | 2.98% | 0.24% | -1.64% | -4.92% |
| Operating Income | 1.51% | 2.63% | 3.87% | 2.06% | 1.72% |
| Income Before Tax | -15.87% | -12.25% | -8.47% | -1.77% | 6.05% |
| Income Tax Expenses | -22.22% | -18.50% | -13.59% | -3.59% | 3.35% |
| Earnings from Continuing Operations | -15.81% | -12.20% | -8.44% | -1.76% | 6.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.81% | -12.20% | -8.44% | -1.76% | 6.04% |
| EBIT | 1.51% | 2.63% | 3.87% | 2.06% | 1.72% |
| EBITDA | 7.18% | 8.43% | 8.99% | 4.68% | 1.71% |
| EPS Basic | -18.75% | -2.94% | 11.11% | 42.86% | 58.44% |
| Normalized Basic EPS | -20.00% | -4.76% | 9.09% | 41.18% | 57.45% |
| EPS Diluted | -18.75% | -2.94% | 11.11% | 42.86% | 58.44% |
| Normalized Diluted EPS | -20.00% | -4.76% | 9.09% | 41.18% | 57.45% |
| Average Basic Shares Outstanding | 0.15% | 0.15% | 0.16% | 99.81% | 56,066.52% |
| Average Diluted Shares Outstanding | 0.15% | 0.15% | 0.16% | 99.81% | 56,066.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |